BOTOX will be featured in several presentations focused on safety, efficacy, and healthcare resource utilization with data evaluating impact on headache severity, headache-related impact, and quality of life in responder and nonresponder
subgroups, and reductions in healthcare resource utilization.
Position t" was not seen in the right hand of the males of treatment nonresponder
A more conservative analytic method is known as the "nonresponder
Furthermore, the IVIG nonresponder
group of KD patients had significantly higher total U-LDH activity, especially U-LDH1 and U-LDH2 levels, than the IVIG responder group.
(2) Is the immune phenotype different between anti-TNF responder and nonresponder
They defined patients with an increase of less than 20% in the CSA measurement as nonresponders
." The results showed that all maneuvers increased the CSA of the right IJV compared to the control condition.9 The researchers also found a considerable number of nonresponder
" (13 of 50 patients) veins in response to all maneuvers.
This limitation may be responsible for the significant rise in HbA1c identified between 3 months and 6 months in the nonresponder
Five Boehringer Ingelheim-sponsored studies assessed the T/A combination in Asian patients with hypertension: two studies on nonresponders
to amlodipine monotherapy (A5 nonresponder
study 1 [NCT00558064], A5 nonresponder
study 2  [NCT01103960]), two studies on nonresponders
to telmisartan monotherapy (T40 nonresponders
study [NCT00550953], telmisartan T80 nonresponders
study [NCT01222520]), and one study on nonresponders
to low-dose T/A combination (T40/A5 nonresponders
Consistently with clinical trials, the incidence of fallers was similar in responder and nonresponder
group in our experience, suggesting that response to PR dalfampridine could not be considered a risk factor for accidental falls.
The responder group was comprised patients who showed a decrease of [DELTA]eGFR during the 6 months after RIT; the patients who showed an increase or no decrease of [DELTA]eGFR after treatment were regarded as nonresponder
group was composed of postoperative AHI > 20 ev/h but inferior to preoperative AHI (improved), postoperative AHI = preoperative AHI (unchanged), and postoperative AHI > preoperative AHI (worsened).
In clinical setting, it is more practical to differentiate responder from nonresponder
rather than to diagnose no residual cancer, because it has been recently shown that patients responding to neoadjuvant therapy had a better survival than patients not responding to neoadjuvant therapy [25-28].